Table 3.

Comparison of selected major societal guideline recommendations for correction of hemostatic parameters prior to high bleeding risk procedures

BSIR 2022EASL 2022ISTH 2021AGA 2021AASLD 2020SIR 201951 
PT/INR Do not correct Do not correct Do not evaluate Do not correct Do not correct INR >2.5* 
Platelets Consider if <50 × 109/L Case by case for <50 × 109/L Do not correct Do not correct Do not correct >30 × 109/L 
Fibrinogen Consider if <1.2  g/l Correction discouraged Do not evaluate No recommendation Do not correct >1  g/L 
BSIR 2022EASL 2022ISTH 2021AGA 2021AASLD 2020SIR 201951 
PT/INR Do not correct Do not correct Do not evaluate Do not correct Do not correct INR >2.5* 
Platelets Consider if <50 × 109/L Case by case for <50 × 109/L Do not correct Do not correct Do not correct >30 × 109/L 
Fibrinogen Consider if <1.2  g/l Correction discouraged Do not evaluate No recommendation Do not correct >1  g/L 

AASLD, American Association for the Study of Liver Disease; AGA, American Gastroenterology Association; EASL, European Association for the Study of Liver Diseases; BSIR, British Society of Interventional Radiology; INR, international normalized ratio; ISTH, International Society of Thrombosis and Haemostasis; PT, prothrombin time; SIR, Society of Interventional Radiology.

*

Give vitamin K if INR >2.5; do not use fresh frozen plasma or prothrombin complex concentrate.

Consider correction prior to planned elective very-high-risk procedures.

or Create an Account

Close Modal
Close Modal